Weekly News Brief March 23–27, 2026
To catch up on all of the news from this past week, listen to our weekly news brief for the week of March 23–27, 2026.
This week’s brief covers a scoping review of AI applications for immunotherapy safety, deep learning to distinguish between thymic epithelial tumor subtypes, and a comparison of large language models' accuracy for answering questions about clinical trials.
To learn more about a review on immunotherapy safety, read "Can AI Improve the Safety of Immune Checkpoint Inhibitors?" or see the source report in JCO Clinical Cancer Informatics.
For more information on thymic tumor classifications, read "Deep Learning Distinguishes Thymic Epithelial Tumor Subtypes," or see the source report in Annals of Oncology.
To learn more about LLM comparisons, read "Study Finds Differences in LLM Accuracy for Answering Patients' Clinical Trial Questions," or see the source report in JCO Oncology Advances.
Disclaimer: This newscast was generated with the assistance of AI tools and avatars. All content is reviewed and approved by the editorial staff of ASCO AI in Oncology. Contact us with any questions.
The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. The mention of any company, product, service, or therapy should not be construed as an endorsement of any kind. Conexiant and ASCO assume no responsibility for any injury or damage to persons or property arising out of or related to any use of material contained in this publication or to any errors or omissions.